Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

Allergic Reactions

Allergic Reactions

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Antiasthma Drugs: Leukotriene Modifiers

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Strategies to overcome perceived barriers to increase physical activity in people with asthma: a prospective study.

ERJ open research·2026

Same author

Embodied Interoception Questionnaire (Intero-10): Development, Validation, and Application in People With Neuropathic Chronic Pain.

European journal of pain (London, England)·2026

Same author

Aerobic training versus behavioural intervention to increase physical activity on clinical control of people with moderate-to-severe asthma: A randomised clinical trial.

Pulmonology·2026

Same author

Calculated globulin as a surrogate marker for hypogammaglobulinemia: establishing clinical decision limits in a Brazilian population cohort.

Frontiers in immunology·2026

Same author

No Time to Bleed! Ultrasound-Guided Management of a Pleural Biopsy Complication: A Case Report.

Respirology case reports·2026

Same author

ERS Congress 2025: highlights from the Airway Diseases Assembly.

ERJ open research·2026

Search research articles

Related Experiment Video

Updated: Feb 26, 2026

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI

Published on: November 1, 2014

Atopy in Elite Endurance Athletes.

Renata N Teixeira¹, Gerson Dos Santos Leite¹, Matteo Bonini²

¹Department of Physical Therapy, University of São Paulo School of Medicine, São Paulo, Brazil.

Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine

|July 15, 2017

Summary

In elite athletes, atopy (specific IgE levels) and allergic symptoms are common. However, this study found no association between atopy and symptoms, suggesting a need for combined screening methods.

More Related Videos

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

Murine Model of Allergen Induced Asthma

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

Related Experiment Videos

Last Updated: Feb 26, 2026

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI

Published on: November 1, 2014

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

Murine Model of Allergen Induced Asthma

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

Area of Science:

Sports Medicine
Allergy and Immunology
Exercise Physiology

Background:

Atopy, characterized by elevated specific immunoglobulin E (IgE) levels, is prevalent in athletes.
Allergic symptoms can impact athletic performance and well-being.

Purpose of the Study:

To determine the frequency of atopy and allergic symptoms in elite endurance athletes.
To investigate the association between atopy and allergic symptoms in this population.

Main Methods:

A cross-sectional study involving 59 elite endurance athletes (triathletes and runners).
Allergic symptoms were assessed using the validated Allergy Questionnaire for Athletes (AQUA).
Atopy was determined by measuring specific IgE levels to inhalant allergens.

Main Results:

The frequency of atopy was 57.6%, and allergic symptoms were reported by 54.2% of the athletes.
No significant association was found between the presence of atopy and reported allergic symptoms.

Conclusions:

Atopy and allergic symptoms are common in elite endurance athletes.
Current screening methods for atopy in athletes may need re-evaluation, considering the lack of association with reported symptoms.